CEACAM5 and neoplasm: Using mice that were transgenic for the human carcinoembryonic antigen (CEA), the vaccine (vaccinia and avipox recombinants expressing CEA and T-cell costimulatory molecules) plus one dose of 6 Gy resulted in dramatic tumor volume reduction.